Elacestrant-d6

Product Description: Elacestrant-d6 (RAD1901-d6) is deuterated labeled Elacestrant (HY-19822) Elacestrant (RAD1901) is an orally available and selective estrogen receptor degrader (SERD) with IC50s of 48 and 870 nM for ERα and ERβ, respectively. Elacestrant also can inhibit growth of ER+ breast cancer cell lines in vitro and in vivo.

Formula: C30H32D6N2O2

References: [1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216./[2]Bihani T, et al. Elacestrant (RAD1901), a Selective Estrogen Receptor Degrader (SERD), Has Antitumor Activity in Multiple ER+ Breast Cancer Patient-derived Xenograft Models. Clin Cancer Res. 2017 Aug 15;23(16):4793-4804./[3]Garner F, et al. RAD1901: a novel, orally bioavailable selective estrogen receptor degrader that demonstrates antitumor activity in breast cancer xenograft models. Anticancer Drugs. 2015 Oct;26(9):948-56.

Molecular Weight: 464.67

Research Area: Cancer

Solubility: 10 mM in DMSO

Target: Estrogen Receptor/ERR;Isotope-Labeled Compounds

• Artikelnummer: MEXHY-19822S3-0
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-19822S3-0
• Verpackungseinheit: Get quote
• Mengeneinheit: STK